Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Melanomas that result from mutations in the gene encoding BRAF often become resistant to BRAF inhibition (BRAFi), with multiple mechanisms contributing to resistance. While therapy-induced autophagy promotes resistance to a number of therapies, especially those that target PI3K/mTOR signaling, its role as an adaptive resistance mechanism to BRAFi is not well characterized. Using tumor biopsies from BRAF(V600E) melanoma patients treated either with BRAFi or with combined BRAF and MEK inhibition, we found that BRAFi-resistant tumors had increased levels of autophagy compared with baseline. Patients with higher levels of therapy-induced autophagy had drastically lower response rates to BRAFi and a shorter duration of progression-free survival. In BRAF(V600E) melanoma cell lines, BRAFi or BRAF/MEK inhibition induced cytoprotective autophagy, and autophagy inhibition enhanced BRAFi-induced cell death. Shortly after BRAF inhibitor treatment in melanoma cell lines, mutant BRAF bound the ER stress gatekeeper GRP78, which rapidly expanded the ER. Disassociation of GRP78 from the PKR-like ER-kinase (PERK) promoted a PERK-dependent ER stress response that subsequently activated cytoprotective autophagy. Combined BRAF and autophagy inhibition promoted tumor regression in BRAFi-resistant xenografts. These data identify a molecular pathway for drug resistance connecting BRAFi, the ER stress response, and autophagy and provide a rationale for combination approaches targeting this resistance pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Inhibition of BRAFV600E with vemurafenib induces autophagy by inhibition of the mTOR signaling pathway, and autophagy has been shown to promote survival of melanoma cells after vemurafenib81,85.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [81]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Induction of autophagy has been suggested to be a pro-survival mechanism for melanoma cells79,81,82.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330 · cited 7×
“LC3 is an ubiquitin-like cytoplasmic protein that is conjugated to the surface of AVs as they are formed.”
InfluentialSelf-citationClonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hauschild, A., Grob, J.-J., Demidov, L. V., Jouary, T., Gutzmer, R., Millward, M., Rutkowski, P., Blank, C. U., Miller, W. H., Kaempgen, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60868-x · Cited by 2,989
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response
Bertolotti, A., Zhang, Y., Hendershot, L. M., Harding, H. P., & Ron, D. (2000) · Nature Cell Biology · doi:10.1038/35014014 · Cited by 2,860
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Self-citationPhosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L.-G., et al. (2006) · Nature Methods · doi:10.1038/nmeth947 · Cited by 2,419 · cited 9×
“PLA was performed using Duolink In Situ fluorescence technology (Olink Bioscience).”
Influential
Cited by
Levy, J. M. M., Towers, C. G., & Thorburn, A. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.53 · Cited by 2,526
The role for autophagy in cancer
White, E. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73941 · Cited by 1,332
Autophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182
Self-citationUPR, autophagy, and mitochondria crosstalk underlies the ER stress response
Senft, D., & Ronai, Z. A. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.01.002 · Cited by 1,121
The impact of the endoplasmic reticulum protein-folding environment on cancer development
Wang, M., & Kaufman, R. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3800 · Cited by 1,112
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, X., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,042
Targeting Autophagy in Cancer: Recent Advances and Future Directions
Amaravadi, R. K., Kimmelman, A. C., & Debnath, J. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0292 · Cited by 928
Self-citationTumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer
Cubillos-Ruiz, J. R., Bettigole, S. E., & Glimcher, L. H. (2017) · Cell · doi:10.1016/j.cell.2016.12.004 · Cited by 895
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Bahar, M. E., Kim, H. J., & Kim, D. R. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01705-z · Cited by 888
“Suppression of RAF -mutant signaling promotes autophagy in cancer cells, 25,26 suggesting that targeting autophagy in cancer cells may be desirable when using pathway-targeted inhibitors in RAF -mutant cancer.”
BackgroundOnorati, A. V., Dyczynski, M., Ojha, R., & Amaravadi, R. K. (2018) · Cancer · doi:10.1002/cncr.31335 · Cited by 837
Self-citationRecent insights into the function of autophagy in cancer
Amaravadi, R., Kimmelman, A. C., & White, E. (2016) · Genes & Development · doi:10.1101/gad.287524.116 · Cited by 813
Self-citationHeat Shock Proteins and Cancer
Wu, J., Liu, T., Rios, Z., Mei, Q., Lin, X., & Cao, S. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.11.009 · Cited by 696
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Bryant, K. L., Stalnecker, C. A., Zeitouni, D., Klomp, J. E., Peng, S., Tikunov, A. P., Gunda, V., Pierobon, M., Waters, A. M., George, S. D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0368-8 · Cited by 692
Self-citationAutophagy and multidrug resistance in cancer
Li, Y.-J., Lei, Y.-H., Yao, N., Wang, C.-R., Hu, N., Ye, W.-C., Zhang, D.-M., & Chen, Z.-S. (2017) · Chinese Journal of Cancer · doi:10.1186/s40880-017-0219-2 · Cited by 665
Autophagy, Metabolism, and Cancer
White, E., Mehnert, J. M., & Chan, C. S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0490 · Cited by 664
The Lysosome as a Regulatory Hub
Perera, R. M., & Zoncu, R. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125125 · Cited by 660
Kinsey, C. G., Camolotto, S. A., Boespflug, A. M., Guillen, K. P., Foth, M., Truong, A., Schuman, S. S., Shea, J. E., Seipp, M. T., Yap, J. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0367-9 · Cited by 634
Crosstalk of autophagy and apoptosis: Involvement of the dual role of autophagy under ER stress
Song, S., Tan, J., Miao, Y., Li, M., & Zhang, Q. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25785 · Cited by 522
Cancer and ER stress: Mutual crosstalk between autophagy, oxidative stress and inflammatory response
Lin, Y., Jiang, M., Chen, W., Zhao, T., & Wei, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109249 · Cited by 501
Autophagy in tumour immunity and therapy
Xia, H., Green, D. R., & Zou, W. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00344-2 · Cited by 404
A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
Cojoc, M., Mäbert, K., Muders, M. H., & Dubrovska, A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.06.004 · Cited by 393
Signal pathways of melanoma and targeted therapy
Guo, W., Wang, H., & Li, C. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00827-6 · Cited by 379
Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate
Corazzari, M., Gagliardi, M., Fimia, G. M., & Piacentini, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00078 · Cited by 376
Mechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
Song, S., Tan, J., Miao, Y., & Zhang, Q. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26137 · Cited by 361
Liu, Y., Zhang, P., Li, F., Jin, X., Li, J., Chen, W., & Li, Q. (2018) · Theranostics · doi:10.7150/thno.22172 · Cited by 335
Persistent Cancer Cells: The Deadly Survivors
Shen, S., Vagner, S., & Robert, C. (2020) · Cell · doi:10.1016/j.cell.2020.10.027 · Cited by 304
Emerging strategies to effectively target autophagy in cancer
Rebecca, V. W., & Amaravadi, R. K. (2016) · Oncogene · doi:10.1038/onc.2015.99 · Cited by 278
Self-citationTherapeutic Targeting of Autophagy
Towers, C. G., & Thorburn, A. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.034 · Cited by 275
Tan, Z., Xiao, L., Tang, M., Bai, F., Li, J., Li, L., Shi, F., Li, N., Li, Y., Du, Q., et al. (2018) · Theranostics · doi:10.7150/thno.21451 · Cited by 271
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance
Cerezo, M., Lehraiki, A., Millet, A., Rouaud, F., Plaisant, M., Jaune, E., Botton, T., Ronco, C., Abbe, P., Amdouni, H., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.013 · Cited by 261
Cellular and metabolic functions for autophagy in cancer cells
Kenific, C. M., & Debnath, J. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.09.001 · Cited by 260
Melanocytic nevi and melanoma: unraveling a complex relationship
Damsky, W. E., & Bosenberg, M. (2017) · Oncogene · doi:10.1038/onc.2017.189 · Cited by 248
Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
Levy, J. M. M., Thompson, J. C., Griesinger, A. M., Amani, V., Donson, A. M., Birks, D. K., Morgan, M. J., Mirsky, D. M., Handler, M. H., Foreman, N. K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0049 · Cited by 246
Regulation of autophagy by canonical and non-canonical ER stress responses
Bhardwaj, M., Leli, N. M., Koumenis, C., & Amaravadi, R. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.007 · Cited by 244
Self-citationPPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer
Rebecca, V. W., Nicastri, M. C., Fennelly, C., Chude, C. I., Barber-Rotenberg, J. S., Ronghe, A., McAfee, Q., McLaughlin, N. P., Zhang, G., Goldman, A. R., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0706 · Cited by 238
Self-citationBoone, B. A., Bahary, N., Zureikat, A. H., Moser, A. J., Normolle, D. P., Wu, W.-C., Singhi, A. D., Bao, P., Bartlett, D. L., Liotta, L. A., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4566-4 · Cited by 234
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Talib, W. H., Alsayed, A. R., Barakat, M., Abu-Taha, M. I., & Mahmod, A. I. (2021) · Biomedicines · doi:10.3390/biomedicines9101353 · Cited by 231
Calcium Homeostasis and ER Stress in Control of Autophagy in Cancer Cells
Kania, E., Pająk, B., & Orzechowski, A. (2015) · BioMed Research International · doi:10.1155/2015/352794 · Cited by 226
Wu, J., Chen, S., Liu, H., Zhang, Z., Ni, Z., Chen, J., Yang, Z., Nie, Y., & Fan, D. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0935-8 · Cited by 223
The multifaceted role of autophagy in cancer
Russell, R. C., & Guan, K. (2022) · The EMBO Journal · doi:10.15252/embj.2021110031 · Cited by 222
Chloroquine and hydroxychloroquine for cancer therapy
Manic, G., Obrist, F., Kroemer, G., Vitale, I., & Galluzzi, L. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29911 · Cited by 222
Functions of autophagy in the tumor microenvironment and cancer metastasis
Mowers, E. E., Sharifi, M. N., & Macleod, K. F. (2018) · The FEBS Journal · doi:10.1111/febs.14388 · Cited by 221
Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
Song, Y., Bi, Z., Liu, Y., Qin, F., Wei, Y., & Wei, X. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.05.006 · Cited by 212
A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles
Rebecca, V. W., Nicastri, M. C., McLaughlin, N., Fennelly, C., McAfee, Q., Ronghe, A., Nofal, M., Lim, C.-Y., Witze, E., Chude, C. I., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0741 · Cited by 209
Self-citationAtg7 Overcomes Senescence and Promotes Growth of Braf V600E-Driven Melanoma
Xie, X., Koh, J. Y., Price, S., White, E., & Mehnert, J. M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1473 · Cited by 208
Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance
Cui, C., Yang, J., Li, X., Liu, D., Fu, L., & Wang, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01180-y · Cited by 206
The multifaceted role of autophagy in cancer and the microenvironment
Folkerts, H., Hilgendorf, S., Vellenga, E., Bremer, E., & Wiersma, V. R. (2019) · Medicinal Research Reviews · doi:10.1002/med.21531 · Cited by 199
Liu, Y., Gong, W., Yang, Z. Y., Zhou, X. S., Gong, C., Zhang, T. R., Wei, X., Ma, D., Ye, F., & Gao, Q. L. (2017) · Apoptosis · doi:10.1007/s10495-016-1334-2 · Cited by 186
Development of encorafenib for BRAF-mutated advanced melanoma
Koelblinger, P., Thuerigen, O., & Dummer, R. (2018) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000426 · Cited by 177
The role of autophagy in resistance to targeted therapies
Mele, L., del Vecchio, V., Liccardo, D., Prisco, C., Schwerdtfeger, M., Robinson, N., Desiderio, V., Tirino, V., Papaccio, G., & La Noce, M. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102043 · Cited by 176
Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors
Mulcahy Levy, J. M., Zahedi, S., Griesinger, A. M., Morin, A., Davies, K. D., Aisner, D. L., Kleinschmidt-DeMasters, B., Fitzwalter, B. E., Goodall, M. L., Thorburn, J., et al. (2017) · eLife · doi:10.7554/elife.19671 · Cited by 175
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons
Akman, M., Belisario, D. C., Salaroglio, I. C., Kopecka, J., Donadelli, M., De Smaele, E., & Riganti, C. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01824-3 · Cited by 174
Mandula, J. K., Chang, S., Mohamed, E., Jimenez, R., Sierra-Mondragon, R. A., Chang, D. C., Obermayer, A. N., Moran-Segura, C. M., Das, S., Vazquez-Martinez, J. A., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.016 · Cited by 173
miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma
Díaz‐Martínez, M., Benito-Jardón, L., Alonso, L., Koetz‐Ploch, L., Hernando, E., & Teixidó, J. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1318 · Cited by 173
Homeostasis control in health and disease by the unfolded protein response
Acosta‐Alvear, D., Harnoss, J. M., Walter, P., & Ashkenazi, A. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00794-0 · Cited by 172
Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
Proietti, I., Skroza, N., Bernardini, N., Tolino, E., Balduzzi, V., Marchesiello, A., Michelini, S., Volpe, S., Mambrin, A., Mangino, G., et al. (2020) · Cancers · doi:10.3390/cancers12102801 · Cited by 145
Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming
García-Jiménez, C., & Goding, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.11.018 · Cited by 150
Intratumoral Heterogeneity: From Diversity Comes Resistance
Pribluda, A., de la Cruz, C. C., & Jackson, E. L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1213 · Cited by 153
Li, S., Song, Y., Quach, C., Guo, H., Jang, G.-B., Maazi, H., Zhao, S., Sands, N. A., Liu, Q., In, G. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09634-8 · Cited by 165
Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization
Pérez-Hernández, M., Arias, A., Martínez‐García, D., Pérez‐Tomás, R., Quesada, R., & Soto‐Cerrato, V. (2019) · Cancers · doi:10.3390/cancers11101599 · Cited by 165
Phenotype Switching in Melanoma: Implications for Progression and Therapy
Li, F. Z., Dhillon, A. S., Anderson, R. L., McArthur, G., & Ferrao, P. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00031 · Cited by 163
Corazzari, M., Rapino, F., Ciccosanti, F., Giglio, P., Antonioli, M., Conti, B., Fimia, G. M., Lovat, P. E., & Piacentini, M. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.183 · Cited by 162
Tameire, F., Verginadis, I. I., & Koumenis, C. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.04.002 · Cited by 129
Self-citationResearch progress of hydroxychloroquine and autophagy inhibitors on cancer
Shi, T., Yu, X., Li-jun, Y., & Xiao, H. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3197-1 · Cited by 153
Recent advances in targeting autophagy in cancer
Jain, V., Singh, M. P., & Amaravadi, R. K. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.02.003 · Cited by 151
Self-citationTargeting the unfolded protein response in cancer
Ojha, R., & Amaravadi, R. K. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.003 · Cited by 131
Self-citationDecoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity
Salvagno, C., Mandula, J. K., Rodríguez, P. C., & Cubillos‐Ruiz, J. R. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.06.006 · Cited by 144
circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637
Zhang, Y., Li, C., Liu, X., Wang, Y., Zhao, R., Yang, Y., Zheng, X., Zhang, Y., & Zhang, X. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.051 · Cited by 131
Targeting quiescent leukemic stem cells using second generation autophagy inhibitors
Baquero, P., Dawson, A., Mukhopadhyay, A., Kuntz, E. M., Mitchell, R., Olivares, O., Ianniciello, A., Scott, M. T., Dunn, K., Nicastri, M. C., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0252-4 · Cited by 129
Self-citationThe unfolded protein response as a target for anticancer therapeutics
Wang, M., Law, M. E., Castellano, R. K., & Law, B. K. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.05.003 · Cited by 131
Interplay between unfolded protein response and autophagy promotes tumor drug resistance
YAN, M.-M., NI, J.-D., SONG, D., DING, M., & HUANG, J. (2015) · Oncology Letters · doi:10.3892/ol.2015.3508 · Cited by 116
Dyczynski, M., Yu, Y., Otrocka, M., Parpal, S., Braga, T., Henley, A. B., Zazzi, H., Lerner, M., Wennerberg, K., Viklund, J., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.028 · Cited by 108
Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment
Cao, Z., Tian, K., Ran, Y., Zhou, H., Zhou, L., Ding, Y., & Tang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1506426 · Cited by 115
Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells
De Conti, G., Dias, M. H., & Bernards, R. (2021) · Cancers · doi:10.3390/cancers13051118 · Cited by 111
“Another common feature of DTP cells is the ability to sustain their metabolism with alternative sources of nutrients such as autophagy or fatty acid oxidation (FAO) pathways [27,35,36].”
BackgroundLi, Z., Jiang, K., Zhu, X., Lin, G., Song, F., Zhao, Y., Piao, Y., Liu, J., Cheng, W., Bi, X., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.015 · Cited by 107
Cancer Cells Upregulate NRF2 Signaling to Adapt to Autophagy Inhibition
Towers, C. G., Fitzwalter, B. E., Regan, D., Goodspeed, A., Morgan, M. J., Liu, C.-W., Gustafson, D. L., & Thorburn, A. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.07.010 · Cited by 96
The unfolded protein response regulates hepatic autophagy by sXBP1-mediated activation of TFEB
Zhang, Z., Qian, Q., Li, M., Shao, F., Ding, W., Lira, V. A., Chen, S. X., Sebag, S. C., Hotamışlıgil, G. S., Cao, H., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1788889 · Cited by 103
Resistance mechanisms to targeted therapy in BRAF-mutant melanoma - A mini review
Tangella, L. P., Clark, M. E., & Gray, E. S. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129736 · Cited by 103
Martin, S., Dudek-Perić, A. M., Garg, A. D., Roose, H., Demirsoy, Ş., Eygen, S. V., Mertens, F., Vangheluwe, P., Vankelecom, H. E. J., & Agostinis, P. (2017) · Autophagy · doi:10.1080/15548627.2017.1332550 · Cited by 101
PERK Integrates Oncogenic Signaling and Cell Survival During Cancer Development
Bu, Y., & Diehl, J. A. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25336 · Cited by 101
Rasche, L., Duell, J., Castro, I. C., Dubljevic, V., Chatterjee, M., Knop, S. T., Hensel, F., Rosenwald, A., Einsele, H., Topp, M. S., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117945 · Cited by 99
Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
Ho, C. J., & Gorski, S. M. (2019) · Cancers · doi:10.3390/cancers11111775 · Cited by 96
Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells
Chien, W., Ding, L., Sun, Q., Fernández, L. T., Tan, S. Z., Xiao, J.-F., Lim, S. L., Garg, M., Lee, K. L., Kitajima, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2051 · Cited by 96
The role of autophagy in cancer: from molecular mechanism to therapeutic window
Jalali, P., Shahmoradi, A., Samii, A., Mazloomnejad, R., Hatamnejad, M. R., Saeed, A., Namdar, A., & Salehi, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1528230 · Cited by 95
Monteleon, C. L., Agnihotri, T., Dahal, A., Liu, M., Rebecca, V. W., Beatty, G. L., Amaravadi, R. K., & Ridky, T. W. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.02.035 · Cited by 94
Self-citationER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma
Ojha, R., Leli, N. M., Onorati, A., Piao, S., Verginadis, I. I., Tameire, F., Rebecca, V. W., Chude, C. I., Murugan, S., Fennelly, C., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0348 · Cited by 91
Self-citationMelanoblast transcriptome analysis reveals pathways promoting melanoma metastasis
Marie, K. L., Sassano, A., Yang, H. H., Michalowski, A. M., Michael, H. T., Guo, T. W., Tsai, Y. C., Weissman, A. M., Lee, M. P., Jenkins, L. M. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14085-2 · Cited by 94
Genomically Driven Tumors and Actionability across Histologies:BRAF-Mutant Cancers as a Paradigm
Turski, M. L., Vidwans, S. J., Jankú, F., Garrido‐Laguna, I., Munoz, J., Schwab, R. B., Subbiah, V., Rodon, J. A., & Kurzrock, R. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0643 · Cited by 93
You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia
Sehgal, A. R., Konig, H., Johnson, D. E., Tang, D., Amaravadi, R. K., Boyiadzis, M., & Lotze, M. T. (2015) · Leukemia · doi:10.1038/leu.2014.349 · Cited by 87
Self-citationTargeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
Kwon, Y., Kim, M.-S., Jung, H. S., Kim, Y., & Jeoung, D. (2019) · Cancers · doi:10.3390/cancers11091374 · Cited by 90
Autophagy is a major metabolic regulator involved in cancer therapy resistance
Poillet-Perez, L., Sarry, J., & Joffre, C. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109528 · Cited by 89
Targeting Mitochondrial Metabolism by Inhibiting Autophagy in BRAF-Driven Cancers
Strohecker, A. M., & White, E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0196 · Cited by 84
Walczak, A., Gradzik, K., Kabziński, J., Przybyłowska-Sygut, K., & Majsterek, I. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5729710 · Cited by 89
Zhou, B., Lu, Q., Liu, J., Fan, L., Wang, Y., Wei, W., Wang, H., & Sun, G. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.32550 · Cited by 87
Protein Quality Control in the Endoplasmic Reticulum and Cancer
Moon, H. W., Han, H. G., & Jeon, Y. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103020 · Cited by 88
Crosstalk between endoplasmic reticulum stress response and autophagy in human diseases
Kwon, J., Kim, J., & Kim, K. I. (2023) · Animal Cells and Systems · doi:10.1080/19768354.2023.2181217 · Cited by 86
Kim, J., & Lee, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091854 · Cited by 85
Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
Nuffel, A. M. T. V. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.513 · Cited by 85
He, J., Zhou, Y. L., & Sun, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01438-0 · Cited by 84
Metadata
- Authors
- Ma, X.-H., Piao, S.-F., Dey, S., Mcafee, Q., Karakousis, G., Villanueva, J., Hart, L. S., Levi, S., Hu, J., Zhang, G., Lazova, R., Klump, V., Pawelek, J. M., Xu, X., Xu, W., Schuchter, L. M., Davies, M. A., Herlyn, M., Winkler, J., Koumenis, C., & Amaravadi, R. K.
- Affiliations
- University of Pennsylvania (US)
- The Wistar Institute (US)
- Yale University (US)
- Abramson Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-02-24
- Volume
- 124
- Issue
- 3
- Pages
- 1406-1417
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3934165
- OpenAlex
- W2119735934
- Cited by
- 457
- References
- 52
- Citations by year
- 2026: 11 · 2025: 36 · 2024: 39 · 2023: 27 · 2022: 37 · 2021: 40 · 2020: 40 · 2019: 35 · 2018: 44 · 2017: 44 · 2016: 48 · 2015: 31 · 2014: 24
- FWCI
- 20.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- National Institutes of Health
- National Cancer Institute (P01CA114046, R01CA139362, K01CA175269, K23CA120862, R01CA169134, R01CA094214, P30CA016672, P30CA010815, P30CA016520)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- melanoma, BRAF inhibitor resistance, BRAF V600E mutation, endoplasmic reticulum stress, autophagy, cytoprotective autophagy, GRP78, PERK, MEK inhibition, autophagy inhibition, combination therapy, PI3K/mTOR signaling, progression-free survival
- MeSH terms
- Vemurafenib, Endoplasmic Reticulum Chaperone BiP, Animals, Antineoplastic Agents, Autophagy, Humans, Indoles, Melanoma, Mice, Nude, Sulfonamides, Drug Resistance, Neoplasm, Mutation, Missense, MAP Kinase Signaling System, Xenograft Model Antitumor Assays, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, Cell Proliferation, Mice, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.